Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Colonic Diseases

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Colonic Diseases in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, Y1
Gong, K1
Zhou, W1
Shao, G1
Li, S1
Lin, Q1
Li, J1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Colonic Diseases

ArticleYear
Involvement of subtypes γ and ε of protein kinase C in colon pain induced by formalin injection.
    Neuro-Signals, 2011, Volume: 19, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Analysis of Variance; Animals; Colonic Diseases; Dise

2011